Myelodysplastic syndromes trials in Sweden
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Gothenburg, Huddinge, Lund, Örebro
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285EU 2024-516009-22-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Örebro
- Age
- 18 years and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414EU 2024-517247-31-00Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Gothenburg, Lund, Stockholm
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060Registry updated 2026-07-01
Phase 1/2RecruitingTrial-stage medicine
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Stockholm
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597Registry updated 2026-06-24
Phase 2RecruitingResearch participation
NMDSG-14B2
- Where
- Goteborg, Huddinge, Linkoping, Lund, Umeå, Uppsala
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2024-511651-17-00EU 2024-511651-17-00Registry updated 2026-05-27
Phase 1/2RecruitingTrial-stage medicine
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Huddinge
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574EU 2023-503244-14-00Registry updated 2025-08-26
Phase 2RecruitingTrial-stage medicine
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
- Where
- Gothenburg, Linköping, Lund, Stockholm, Uppsala
- Age
- 18 years to 45 years
- People
- 100
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06793410Registry updated 2025-06-05
Phase 2RecruitingResearch participation
Combining Active and Passive DNA Hypomethylation
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Age
- 18 years and over
- People
- 196 worldwide
- Run by
- Kirsten Grønbæk
See details and how to joinNCT03999723Registry updated 2024-04-17
Phase 2RecruitingTrial-stage medicine
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Where
- Stockholm
- Age
- 18 years and over
- People
- 200
- Run by
- Karolinska University Hospital
See details and how to joinNCT05788679Registry updated 2023-12-05
All Myelodysplastic syndromes trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.